Gj. Grover et al., EMS-180448, A NOVEL GLYBURIDE-REVERSIBLE CARDIOPROTECTIVE AGENT, ENHANCES POSTISCHEMIC RECOVERY OF CONTRACTILE FUNCTION IN DOGS, The Journal of pharmacology and experimental therapeutics, 276(2), 1996, pp. 380-387
BMS-180448 has been found to retain the cardioprotective potency of it
s chemically related analog, cromakalim, although having significantly
less peripheral vasodilating activity. The effect of the ATP-sensitiv
e potassium channel opener, BMS-180448, on postischemic recovery of fu
nction (segmental shortening) was determined in open chested, anesthet
ized dogs instrumented with ultrasonic crystals. The plasma-concentrat
ion of the effective and ineffective doses of BMS-180448 was compared
to concentrations used in isolated rat hearts. BMS-180448 was given as
a total dose of 4.2, 1.4 or 0.5 mg/kg over 30 min, starting 15 min be
fore ischemia. Ischemia was initiated by a complete occlusion of the l
eft anterior descending coronary artery for 15 min. Reperfusion was ma
intained for 3 hr and segmental shortening was measured. During ischem
ia, systolic bulging was observed in the ischemic region in drug and v
ehicle-treated groups. Upon reperfusion, some contractile functional r
ecovery was observed in vehicle-treated controls within minutes, but q
uickly decreased so that slight bulging was observed up to 3 hr into r
eperfusion. High dose BMS-180448 significantly improved the recovery o
f contractile function such that, by 3 hr after reperfusion, segmental
shortening had recovered to 60% of base line. The 1.4-mg/kg dose also
significantly improved reperfusion function, but 0.5 mg/kg of BMS-180
448 was without effect. None of the doses of BMS-180448 significantly
affected peripheral hemodynamic status or collateral blood flow. The p
lasma concentration of the 1.4-mg/kg dose was approximately 3 mu M dur
ing ischemia. In isolated rat hearts, BMS-180448 significantly increas
ed postischemic function at 3 mu M and higher concentrations, which ag
rees with the dog data. BMS-180448 was protective in a dose-dependent
manner in a canine model of stunned myocardium, and the concentrations
necessary for protection are similar to that for rats.